These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12489603)

  • 21. Syringe access for the prevention of blood borne infections among injection drug users.
    Stancliff S; Agins B; Rich JD; Burris S
    BMC Public Health; 2003 Nov; 3():37. PubMed ID: 14633286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003.
    Deibert RJ; Goldbaum G; Parker TR; Hagan H; Marks R; Hanrahan M; Thiede H
    Am J Public Health; 2006 Aug; 96(8):1347-53. PubMed ID: 16809607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deregulation of syringes and needles for medical use and to prevent the spread of blood-borne pathogens among illicit injection drug users.
    Morse LJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S143-4. PubMed ID: 9663640
    [No Abstract]   [Full Text] [Related]  

  • 24. Increasing legal and regulatory support for pharmacy syringe sales to injection drug users, Washington State, 1999-2002.
    Williams DH
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S23-4. PubMed ID: 12489607
    [No Abstract]   [Full Text] [Related]  

  • 25. Barriers to Access to Sterile Syringes as Perceived by Pharmacists and Injecting Drug Users: Implications for Harm Reduction in Lebanon.
    Ghaddar A; Nassar K; Elsoury G
    Subst Use Misuse; 2017 Sep; 52(11):1420-1428. PubMed ID: 28430013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Community syringe collection and disposal policies in 16 states.
    Turnberg WL; Jones TS
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S99-104. PubMed ID: 12489626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.
    Wright-De Agüero L; Weinstein B; Jones TS; Miles J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S102-10. PubMed ID: 9663632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Federal law and syringe prescription and dispensing.
    Abrahamson D
    Health Matrix Clevel; 2001; 11(1):65-71. PubMed ID: 11345677
    [No Abstract]   [Full Text] [Related]  

  • 29. Syringe exchange programs: Impact on injection drug users and the role of the pharmacist from a U.S. perspective.
    Nacopoulos AG; Lewtas AJ; Ousterhout MM
    J Am Pharm Assoc (2003); 2010 Mar-Apr 1; 50(2):148-57. PubMed ID: 20199955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What do pharmacists think about New York state's new nonprescription syringe sale program? Results of a survey.
    Klein SJ; Harris-Valente K; Candelas AR; Radigan M; Narcisse-Pean M; Tesoriero JM; Birkhead GS
    J Urban Health; 2001 Dec; 78(4):679-89. PubMed ID: 11796814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Public health interventionists, penny capitalists, or sources of risk?: assessing street syringe sellers in Hartford, Connecticut.
    Stopka TJ; Singer M; Santelices C; Eiserman J
    Subst Use Misuse; 2003 Jul; 38(9):1345-77. PubMed ID: 12908815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reported experiences during syringe purchases in Providence, Rhode Island: implications for HIV prevention.
    Zaller ND; Yokell MA; Apeakorang N; Gaggin J; Case P
    J Health Care Poor Underserved; 2012 Aug; 23(3):1310-26. PubMed ID: 24212176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Following the blood: syringe reuse leads to blood-borne virus transmission among injection drug users.
    Koester S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S139-40. PubMed ID: 9663637
    [No Abstract]   [Full Text] [Related]  

  • 34. A duty to care: sterile injection equipment and illicit-drug use.
    Novick A
    AIDS Public Policy J; 1996; 11(2):63-5. PubMed ID: 10915239
    [No Abstract]   [Full Text] [Related]  

  • 35. Parenteral transmission of HIV among injection drug users: assessing the frequency of multiperson use of needles, syringes, cookers, cotton, and water.
    McCoy CB; Metsch LR; Chitwood DD; Shapshak P; Comerford ST
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S25-9. PubMed ID: 9663620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New York State pharmacists' attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation.
    Linas BP; Coffin PO; Backes G; Vlahov D
    J Urban Health; 2000 Dec; 77(4):768-80. PubMed ID: 11194316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley.
    Pollini RA
    J Am Pharm Assoc (2003); 2017; 57(6):677-685. PubMed ID: 28807658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Community-based programs for safe disposal of used needles and syringes.
    Macalino GE; Springer KW; Rahman ZS; Vlahov D; Jones TS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S111-9. PubMed ID: 9663633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacy student knowledge, attitudes, and beliefs about selling syringes to injection drug users.
    Blumenthal WJ; Springer KW; Jones TS; Sterk CE
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S34-9. PubMed ID: 12489613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The legal environment impeding access to sterile syringes and needles: the conflict between law enforcement and public health.
    Gostin LO
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S60-70. PubMed ID: 9663626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.